Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia
Titel:
Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia
Auteur:
Jain, Nitin Stock, Wendy Zeidan, Amer Atallah, Ehab McCloskey, James Heffner, Leonard Tomlinson, Benjamin Bhatnagar, Bhavana Feingold, Jay Ungar, David Chao, Grace Zhang, Xiaoyan Qin, Yajuan Havenith, Karin Kantarjian, Hagop Wieduwilt, Matthew J.